DIAGNOSIS AND TREATMENT HISTORY BEFORE PSORIASIS DIAGNOSIS AMONG PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS

被引：0
|
作者：
Feldman, S. R. [1 ]
Zhao, Y. [2 ]
Hur, P. [2 ]
Liu, J. S. [3 ]
Herrera, V [2 ]
机构：
[1] Wake Forest Baptist Med Ctr, Winston Salem, NC USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Harvard Univ, Cambridge, MA 02138 USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS4
引用
收藏
页码：A156 / A156
页数：1
相关论文
共 50 条
  • [41] Patients' perspectives on the impact of moderate-to-severe genital psoriasis
    Cather, Jennifer Clay
    Bleakman, Alison Potts
    Naegli, April
    Poon, Jiat Ling
    Wallace, Ashley
    Hollister, Kristin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB192 - AB192
  • [42] Onset of Action of Biologics in Patients With Moderate-to-Severe Psoriasis
    Papp, Kim A.
    Lebwohl, Mark G.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2018, 17 (03) : 247 - 250
  • [43] Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis
    Dauden, E.
    Prieto-Perez, R.
    Llamas-Velasco, M.
    Cabaleiro, T.
    Abad-Santos, F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S188 - S188
  • [44] Managing Moderate-to-Severe Psoriasis in the Elderly
    Balato, Nicola
    Patruno, Cataldo
    Napolitano, Maddalena
    Patri, Angela
    Ayala, Fabio
    Scarpa, Raffaele
    DRUGS & AGING, 2014, 31 (04) : 233 - 238
  • [45] Managing Moderate-to-Severe Psoriasis in the Elderly
    Nicola Balato
    Cataldo Patruno
    Maddalena Napolitano
    Angela Patrì
    Fabio Ayala
    Raffaele Scarpa
    Drugs & Aging, 2014, 31 : 233 - 238
  • [46] Risankizumab in moderate-to-severe plaque psoriasis
    Serrano, Linda
    Maloney, Victoria
    Gordon, Kenneth B.
    IMMUNOTHERAPY, 2019, 11 (16) : 1357 - 1370
  • [47] Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis
    María C. Ovejero-Benito
    Ester Muñoz-Aceituno
    Alejandra Reolid
    Miriam Saiz-Rodríguez
    Francisco Abad-Santos
    Esteban Daudén
    American Journal of Clinical Dermatology, 2018, 19 : 209 - 222
  • [48] Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis
    Ovejero-Benito, Maria C.
    Munoz-Aceituno, Ester
    Reolid, Alejandra
    Saiz-Rodriguez, Miriam
    Abad-Santos, Francisco
    Dauden, Esteban
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (02) : 209 - 222
  • [49] Nail Psoriasis Does Not Affect Skin Response to Ixekizumab in Patients With Moderate-To-Severe Psoriasis
    Rich, Phoebe
    Goldblum, Orin
    Disch, Damon
    Lin, Chen-Yen
    Merola, Joseph F.
    Elewski, Boni
    JOURNAL OF DRUGS IN DERMATOLOGY, 2020, 19 (08) : 741 - 746
  • [50] The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection
    Tsai, T. -F.
    Ho, V.
    Song, M.
    Szapary, P.
    Kato, T.
    Wasfi, Y.
    Li, S.
    Shen, Y. K.
    Leonardi, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (05) : 1145 - 1152
12345